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Abstract 
Background: Autophagy is a physiologic process in which double membrane vesicles engulf damaged proteins and 
organelles for delivering them to lysosome in order to degrade and recycle them via lysosomal digestion. Beclin1 is 
one of the basic proteins involved in the initial step of auto phagosome formation. In the current study, the effects of 
exogenous Beclin1 and 3-methyladenine (3-MA) to induce and inhibit of autophagy were assessed in Huh7.5 cells as 
an in vitro models of hepatocellular carcinoma. Materials and Methods: The recombinant pcDNA-Beclin1was 
transfected into Huh7.5 cells. Also, the cytotoxicity of 3-methyladenine (3-MA) were determined in Huh7.5 cells 
and the cells were treated with 3-methyladenine (3-MA). The autophagy induction and inhibition was conducted via 
LC3 staining as a main autophagy marker using flowcytometry. Results: The result of this study suggest that the 
over expression ofexogenousBeclin1 in Huh7.5 cells elevated the autophagosome formation as shown by 
intracellular autophagosomal marker LC3-II staining for about 32.32 % and  3-MA decreased  it up to2% compared 
with control cells in which the  stained LC3-II was12.08.The IC50 of 3-methyladenine (3-MA)   was 7.2 mM in 
Huh7.5 cells. Conclusion: Recombinant beclin1 may be used as a potential autophagy inducer agent and3-
methyladenine (3-MA)   inhibits autophagy formation in Huh7.5 cell. The staining autophagy formation marker 
LC3-II with specific antibody is a reliable method to measure autophagy activation via flow cytometry. 
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Autophagy is a preserved intracellular 
homeostatic process by which the cell cleans out 
different types of cytoplasmic debris(1). During the 
autophagy process, Beclin-1 and microtubule-
associated protein 1 light chain3 (LC3) are connected 
with the initial steps of autophagosome formation 
and autophagosome maturation, respectively(2). To 
start autophagy, Beclin 1 is an initiator complex that 
acts as a platform for nucleation step of autophagy. 
One of the key biological markers frequently used to 
show autophagy maturation in mammalian systems is 
the microtubule associated protein 1A/1Blight chain 3 
(LC3). During elongation of the phagophore, cytosolic 
LC3-1 is conjugated to phosphatidylethanolamine to 
form LC3-II. LC3-II is recruited and inserted into the 
autophagosomal membrane(3). Finally, the delivery of 
autophagosomes to lysosomes and degradation takes 
place(4). 
Failure in autophagy causes the accumulation of 
intracellular macromolecules including unfolded and 
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damaged proteins, damaged organelles and 
chromatin instability DNA .The most important mark 
to show the role of autophagy in tumor suppression is 
a study carried out on the interaction between Bcl2 
and Beclin 1 proteins. Deletion of Beclin1 has been 
mounted in prostate cancer, breast, ovarian both in 
humans and mice. Activation of PI3K-AKT-
mTORpathwaythat inhibits autophagy is a dominant 
condition for cancer culminating in tumor cell 
survival and proliferation. In contrast, tumor-
suppressor proteins such as RB, P53 and phosphates 
have a positive role on autophagy formation(5). 
Hepatocellular carcinoma (HCC) is an 
aggressive form of cancer and is the fifth most 
common cause of cancer death worldwide(6).The 
interaction between apoptosis and autophagy is 
remained as debated issue particularly in HCC. 
Hence, molecular mechanisms contributed to chemo 
resistance of HCC may result in improved clinical 
results. Among the several parameters , therapy-
induced autophagy indicate a novel approach of 
resistance to  combat against cancer(7). 
Throughout dysplastic stage in hepatocytes, 
basal autophagy able to suppress tumor suppressor 
via eliminating newly damaged mitochondria and 
gnomically unstable cell to maintain genomic 
stability. Autophagy inhibitors lead to tumor 
suppression in tumor-forming stage in the HCC rat 
model, but result in tumor-promotion in dysplastic 
phase. For this reason, the autophagy plays  like two 
edge sward  in the generation and progression of 
HCC based on the context of liver cells(8). 
Interestingly, evidence has been mounting that 
autophagy itself may be another cell death 
mechanism, termed programmed cell type II or 
autophagic cell death (ACD), emphasizing a 
potential pro-death role for autophagy ACD is 
characterized by the accumulated cytoplasmic 
vacuolization, absence of chromatin condensation, 
LC3 lipidation and caspase-independent 
apoptosis(9). 
Huh7.5 is derivative of Huh-7 cells (is a 
human hepatocyte-derived carcinoma cell line)  
that shows significantly superior permissiveness to 
replication of HCV. Huh7.5 cells are the RIG-I 
pathway deficient cells, making them less sensitive to 
intracellular dsRNA throughout virus replication and 
eliciting an antiviral response(10).The manipulation of 
autophagy in Huh7.5 can aid to clear the cross-talk 
between intracellular innate responses and viral 
immunopathogenesis. The aim of this study was to 
optimize the autophagy induction with recombinant 
Beclin and autophagy inhibition using 3-
methyladenine (3-MA)  by staining the intracellular 
autophagosomal marker LC3-II using flow 
cytometry(11) . 
Methods 
Plasmid construction. The recombinant 
plasmid pcDNA3.1 containing Beclin 1was gifted by 
Dr. Asghar Abdoli (Pasteur Institute of Iran).The 
vector was transferred into Escherichia coli(E. coli) 
strain DH5a and the plasmid was purified from an 
overnight culture of E. coli by using Miniprep Kit 
(Genetbio, Korea).(The Victor is 4,000 bp and the 
Beclin-1 gene is 1600 bp).The quality and 
concentration of purified plasmid DNA were 
controlled using agarose gel electrophoresis together 
with measuring optical density (OD) of DNA at wave 
lengths of 260 nm and 280 nm. 
MTT assay and IC50 determination. 
Autophagy inhibitor, 3-methyladenine (3-MA) is a 
synthetic compounds and a cell permeable autophagic 
blocker through the inhibition of class III PI3K.To 
evaluate the toxicity of 3-methyladenine (3-MA) on 
cell viability, colorimetric MTT assay was carried out. 
Yellow3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl 
tetrazolium bromide (MTT), a water-soluble dye that 
is readily taken up by viable cells and reduced to 
purple formazan through  mitochondrial succinate 
dehydrogenase. Briefly, to make stock MTT (10x), 
tetrazolium at a concentration of 5 mg/ml was 
dissolved in PBS (Phosphate Buffer Saline) and 
filtering via 0.45 μm filter. The medium of the treated 
cell with different 10 fold diluted 3-methyladenine (3-
MA) was replaced with 100 μl of 1x MTT per well. 
After incubation at 37°C with 5% CO2 for 4 h, 
formazan crystals were dissolved in 100 μl dimethyl 
sulfoxide and shaked to release the color from the 
cells. Finally, Optical density was measured at 570 nm 
and 630nm using ELISA reader to determine live 
cells(12). 
Cell culture and treatment. One day before 
transfection 2 × 105 Huh7.5 cells were seeded into in 
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six-well culture plates in DMEM supplemented with 
10% fetal calf serum 100 IU/ml penicillin and 100 
mg/ml streptomycin and incubated in the presence of 
5 % CO2 incubator. After reaching 80% confluency, 
the growth medium was removed from cells and 
washed for two times with PBS buffer. In the next 
step, cells were transfected with 5µg of  pcDNA-
beclin 1 for expression of Beclin 1 or the empty 
vector as control using lipofectamine 2000(Sigma 
Company, Germany) based on manufacturer 
protocol. Also, to inhibit autophagy, Huh-7.5 cells 
were treated with different concentrations of 3-
methyladenine (3-MA) ranging from 1 to 10 mM of  
3-methyladenine (3-MA)(13). 
Detection of autophagy induction by flow 
cytometry. Tracking the LC3-I to LC3-II conversion 
is indicative of autophagic activity which is recruited 
to autophagosomal membranes. LC3-II is one of the 
central proteins of the autophagosome membrane that 
is present in both the inner and outer site of the 
autophagosome membrane. In the current study, 
activation of autophagy was verified via 
autophagosomal marker LC3-II detection using 
specific antibodies and flow cytometry. Briefly, after 
fixation with 4% formaldehyde for 15 min and 
washing with PBS, the monolayer cells were 
permeabilized by adding 0.1% Triton X-100 in PBS 
for 15 minutes at 37° C. After removing Triton, the 
cells were covered by primary antibody diluted in 
PBS containing 1% BSA for 1h on ice. Finally, 
FITC-conjugated secondary antibody (Abcam, USA) 
was added and incubated at room temperature for 1h. 
The stained cells were studied by flow 
cytometry(Partec, Germany).Cells transfected with 
pcDNA empty vector were used as the negative 
control(14). 
Statistical analysis. To provide data, the 
measures of central tendency were calculated by 
using mean for each well. 
Results 
Cell culture. Huh7.5 cells reached the desired 
confluency in terms of number and morphology after 
passages were shown in Figure 1. 
MTT assay and IC50 determination. The 
percentage of the viability cells against different 
concentration of 3-methyladenine (3-MA) using 
MTT assay was determined. Figure 2 shows the 
viability of Huh7.5 cells following exposure to 
different concentrations of 3-methyladenine (3-
MA).The IC50 values of 3-methyladenine (3-MA) are 
obtained from the dose response curves (figures 3).The 




Figure 1. Inverted microscopic image of Huh7.5 cells after 48 






Figure 2. Cell Viability of Huh7.5 cells after 24 hours treatment 





Figure 3. The dose–effect curve of 3-methyladenine (3-MA). 
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Induction of autophagy in Huh7.5 by 
exogenous Beclin 1. LC3 is the one of main reliable 
marker of autophagosomes formation. We tested the 
ability of Beclin 1 to trigger autophagy in Huh7.5 
cells using monoclonal antibody through staining 
LC3-II. As can be seen in Figure 4, 32.32 % of the 
cells were LC3-II positive in the experiment sample 
in comparison with the LC3-II expression level in 
control cell which was 12.08%, as shown in Figure 5. 
 
Autophagy inhibition via 3MA. 3-
Methyladenine (3-MA) is an autophagy inhibitor and 
selectively blocks PI3K.So we tested the capability 
of 3-Methyladenine (3-MA) in inhibition of 
autophagy in Huh7.5 cells. It reduced autophagy 
formation up to 2.2%in comparison with the LC3-II 
expression level in control cell which was 12.08%, as 
demonstrated in Figure 6. 
Discussion 
In cancer cells, metabolic stress is because of 
inadequate nutrition or decreased storage oxygen and 
increased require for quick cell division, induced 
autophagy because of cell search for energy source 
and metabolism alternatives. Also, autophagy may be 
a response to acquired cancer cells in cancer 
treatments which leads to drug resistance and cancer 
cell survival. Suppression of autophagy via drugs 
including3-methyladenine (3-MA) make the cancer 
cells sensitive to a variety range of therapeutic 
models(15). 
Parallel with this study, Kabeya Y and 
colleagues reported that conversion of LC3-I to LC3-II 
was repressed by 3-methyladenine (3-MA)(16). These 
results verified the autophagy inhibitory effects of 3-
MA under normal conditions. In line with our studies, 
Tajo and et al. showed that Beclin 1 overexpression 
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Region Gate Count Count/ml %Gated Mean-x CV-x% Mean-y CV-y%
R1 <None> 12841   -    64.20 83.65   69.98 44.70   78.43
Q1 R1 72      -    0.56 29.83   13.58 7.32    113.79
Q2 R1 4150    -    32.32 151.23  36.32 18.04   71.10
Q3 R1 2063    -    16.07 30.44   13.09 0.20    84.16
Q4 R1 6556    -    51.06 58.20   31.38 0.32    74.13  
 
Figure 4. Autophagy induction by recombinant Beclin1.The staining intracellular 
marker of autophagy formation demonstrated that the 32.32 % of the cells were 
LCII positive when transfected with pCDNA-Beclin1 as autophagy inducer 
construct. 
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Region Gate Count Count/ml %Gated Mean-x CV-x% Mean-y CV-y%
R1 <None> 13797   -    68.98 64.26   67.69 48.08   77.50
Q1 R1 29      -    0.21 31.11   14.76 4.93    93.42
Q2 R1 1667    -    12.08 159.90  30.84 11.99   63.68
Q3 R1 3010    -    21.82 30.44   12.75 0.19    78.74
Q4 R1 9091    -    65.89 58.03   30.96 0.27    76.83  
 
Figure 5. Autophagy evaluation after empty pCDNA3.1 plasmid transfection as 
a control. The Huh 7.5 cells were transfected with empty pCDNA3.1 stained with 
specific antibody to determine LC3II positive cells. Approximately, 12.08 % of 
cells were LC3II positive after staining. 
 
File: 23   Date: 04-02-2010  Time: 12:44:26    Particles: 24108   Acq.-Time: 20 s












































Q1: 0.16% Q2: 2.90%














Region Gate Count Count/ml %Gated Mean-x CV-x% Mean-y CV-y%
R1 <None> 16086   -    66.72 54.02   49.01 56.01   72.11
Q1 R1 25      -    0.16 29.59   12.52 5.18    111.29
Q2 R1 466     -    2.90 139.06  43.00 9.65    119.88
Q3 R1 3724    -    23.15 30.50   12.64 0.17    78.17
Q4 R1 11871   -    73.80 58.12   31.23 0.26    78.54  
 
Figure 6. Autophagy inhibition using 3-methyladenine (3-MA).The class III 
PI3K blocker 3-methyladenine (3-MA) is used to inhibit autophagy activation 
and it reduced autophagy formation up to 2.80 %. 
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induces autophagy in HeLa cells. They observed a 
number of LC3-positive cells by flow cytometry 
analysis in HeLa cells transfected with pcDNA-
Beclin 1. The Beclin 1 overexpression effect on 
autophagy formation in transfected cells was more 
than that of the control group. In total, 51.7% of the 
cells were LC3-II positive in the experiment 
samples(17). 
LC3 immunostained cells showed fewer 
numbers of punctuated stained cells on 3-
methyladenine (3-MA) plus I2 treatment as 
compared to I2 treatment alone, suggesting 
disruption of autophagosome formation. In addition, 
inhibition of autophagy with PI3K (3-MA, 
LY294002) or H+/ATPase (bafilomycin) inhibitors 
enhance the cytotoxic response of I2. These data 
suggest that autophagy is acting as survival 
mechanism while extensive damage may be 
responsible for cytotoxic response in I2 treated 
cancer cells(18). 
Differential effects of the autophagy inhibitors 
3-methyladenine (3-MA) and chloroquine on the 
control of autophagy on HL60 cancer cells, was 
shown that treating with 3-methyladenine (3-
MA),showed no significant change in the LC3-ll 
bands using Western blotting, while in the cells 
incubated with chloroquine, a significant increase in 
the expression of this protein was observed. Based on 
these observations, it is hypothesized that depending 
on the stage of the autophagy process that is targeted 
for the drug, the type of response to the drug in the 
amount of expression of various genes involved in 
autophagy can be different(19). 
Demishtein A and et al., were reported when 
chloroquine or bafilomycin A1 are cultured 
separately with neuronal coronal cells lead to 
autophagy inhibition by measuring and observing the 
LC3-ll protein(20).3-methyl adenine(3-MA) can 
suppress proteolysis even in Atg5-deficient cells, 
suggesting that its effects on protein degradation 
extend beyond its role in autophagy inhibition(21). 
In this study, after treating the Huh7.5 cells 
with 3-methyladenine (3-MA), the expression of 
LC3-ll was measured by flowcytometry and it 
decreased autophagy marker compared to the control 
cell. To induce autophagy, Beclin1 transfected 
Huh7.5 cells showed significant increases in 
expression of LC3-ll, compared to control cells. 
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